These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30007542)

  • 1. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of efficacy and complications between transrectal and transperineal prostate biopsy with or without antibiotic prophylaxis.
    He J; Guo Z; Huang Y; Wang Z; Huang L; Li B; Bai Z; Wang S; Xiang S; Gu C; Pan J
    Urol Oncol; 2022 May; 40(5):191.e9-191.e14. PubMed ID: 35168882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
    Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
    Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Propensity Score-matched Comparison of Micro-ultrasound-guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer.
    Piccolini A; Avolio PP; Saitta C; Beatrici E; Moretto S; Aljoulani M; Dagnino F; Maffei D; Frego N; Fasulo V; Paciotti M; Hurle R; Saita A; Lazzeri M; Casale P; Colombo P; Cieri M; Buffi NM; Lughezzani G
    Eur Urol Open Sci; 2024 Nov; 69():7-12. PubMed ID: 39314912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: A propensity score-matched study.
    Jiang CY; Shen PF; Wang C; Gui HJ; Ruan Y; Zeng H; Xia SJ; Wei Q; Zhao FJ
    Asian J Androl; 2019; 21(6):612-617. PubMed ID: 31006712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between Ultrasound Guided Transperineal and Transrectal Prostate Biopsy: A Prospective, Randomized, and Controlled Trial.
    Guo LH; Wu R; Xu HX; Xu JM; Wu J; Wang S; Bo XW; Liu BJ
    Sci Rep; 2015 Nov; 5():16089. PubMed ID: 26526558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
    [No Abstract]   [Full Text] [Related]  

  • 10. Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications.
    Oderda M; Diamand R; Abou Zahr R; Anract J; Assenmacher G; Barry Delongchamps N; Bui AP; Benamran D; Calleris G; Dariane C; Ferriero M; Fiard G; Taha F; Fourcade A; Fournier G; Guenzel K; Halinski A; Marra G; Ploussard G; Rysankova K; Roche JB; Simone G; Windisch O; Gontero P
    World J Urol; 2024 Sep; 42(1):535. PubMed ID: 39320521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
    Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
    Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
    Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
    Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    Seitz M; Stief C; Waidelich R; Bader M; Tilki D
    World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
    Diamand R; Guenzel K; Mjaess G; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Bui AP; Taha F; Oderda M; Gontero P; Rysankova K; Bernal-Gomez A; Mastrorosa A; Roche JB; Fiard G; Abou Zahr R; Ploussard G; Windisch O; Novello Q; Benamran D; Delavar G; Anract J; Barry Delongchamps N; Halinski A; Dariane C; Benijts J; Assenmacher G; Roumeguère T; Peltier A
    Eur Urol Focus; 2024 Sep; 10(5):805-811. PubMed ID: 38508895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis.
    Noreikaite J; Jones P; Fitzpatrick J; Amitharaj R; Pietropaolo A; Vasdev N; Chadwick D; Somani BK; Rai BP
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):153-160. PubMed ID: 29487398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
    Ongün S; Aslan G; Avkan-Oguz V
    Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.